| Literature DB >> 25641766 |
Martin Pejchinovski1, Dajana Hrnjez1, Adela Ramirez-Torres1, Vasiliki Bitsika2, George Mermelekas2, Antonia Vlahou2,3, Petra Zürbig1, Harald Mischak1,4, Jochen Metzger1, Thomas Koeck1.
Abstract
Clinical proteomics, a rapidly growing field, intends to use specific diagnostic proteomic/peptidomic markers for initial diagnosis or prognosis of the progression of various diseases. Analyses of disease-associated markers in defined biological samples can provide valuable molecular diagnostic information for these diseases. This approach relies on sensitive and highly standardized modern analytical techniques. In the recent years, one of these technologies, CZE online coupled to MS (CZE-MS), has been increasingly used for the detection of peptide biomarkers (<20 kDa) in body fluids such as urine. This review presents the most relevant urinary proteomic studies addressing the application of CZE-MS in clinically relevant biomarker research between the years 2006 and 2014.Keywords: Biomarker; Capillary electrophoresis-mass spectrometry; Clinical; Proteomics
Mesh:
Substances:
Year: 2015 PMID: 25641766 DOI: 10.1002/prca.201400113
Source DB: PubMed Journal: Proteomics Clin Appl ISSN: 1862-8346 Impact factor: 3.494